Aflac Incorporated

US$124.06As of Sun 8 Nov 2026, 12:00 UTC
NYSE:AFLFinancials
Country USA
PE (Fwd) •••
TSR 10Y CAGR 16.30%
Div yield 1.97%
ROE 12.16%
Insurance (Life)
Beta (5Y) 0.55
PE TTM 17.96
TSR TTM 18.16%
Mkt cap US$61.36B
Combined —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$148
19.69%
(88.96%)
Hold 7|4|1|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.65
1.79
1.91
2.03
(4.59%)
8.84%
12.06%
19.58%
Revenue$B
6.476
6.509
6.719
7.033
(0.82%)
2.75%
4.81%
5.57%
Peers (US$61.36B)
Cap (US$)
PE
61.76B
12.87x
11.89B
51.06x
62.61B
7.648x
Capital
TTM
5Y
10Y
Leveragex
0.711
—
—
EBIT/Intx
0.396
0.551
0.524
Own earn%
—
—
—
Sh yield%
19.48
22.96
22.20
Owners
Insiders/Inst%
8.40
45.25
Short interest%
1.50
SBC / revenue%
0.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
24–29
$1 testx
0.0
Incr. ROIC%
—

Aflac Incorporated provides supplemental health and life insurance across two segments: Aflac Japan, offering cancer, medical, nursing care, whole life and GIFT products in Japan, and Aflac U.S., offering accident, disability, cancer, critical illness, hospital indemnity, dental, vision and life cover in the United States. It sells to individuals, families and business owners through agencies, banks, career agents and brokers.